Life Bio reaches first clinical milestone for OSK therapy
First patient dosed in Phase 1 trial testing epigenetic restoration approach for progressive age-related vision loss. The longevity…
FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
Is Altos Labs gearing up for clinical trials?
Appointment of Joan Mannick as CMO is a sign that company’s cellular rejuvenation programs may be nearing readiness…